Sector Update: Healthcare


Healthcare shares are mixed in pre-market trade. Repligen Corporation ( RGEN ) says it received a $1 million milestone payment from Pfizer ( PFE ) under the terms of the companies' exclusive worldwide licensing agreement for the development of compounds to treat spinal muscular atrophy. RGEN is flat in pre-market trade.

This first milestone payment was triggered by completion of specific program activities and coincides with the successful completion of all transition obligations by RGEN.

And, Rockwell Medical ( RMTI ) surged nearly 11% in pre-market trading to $6.10 after saying its iron-delivery drug SFP for the treatment of iron deficiency in chronic kidney disease patients receiving hemodialysis met primary and key secondary endpoints in a phase 3 efficacy study.

In dialysis patients not receiving intravenous iron, SFP effectively delivered it via dialysate. The drug also appears safe and effective as an iron replacement therapy that maintains hemoglobin levels without increasing iron stores.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities

Referenced Stocks: PFE , RGEN , RMTI

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by